CGS vs CUV

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

57MEDIUM

CUV

CLINUVEL FPO [CUV]

62MEDIUM-HIGH

Score Breakdown

CGS CUV
Technical
61
39
Catalyst
55
54
Sentiment
50
50
Fundamental
99
91
Momentum
64
47
Risk Gate
45
40

Key Metrics

CGS Metric CUV
$523.4MMarket Cap$419.1M
699KAvg Volume (20d)167K
+0.0%Short Interest+8.1%
$3.23052-Week High$13.480
$1.69052-Week Low$8.010
-0.3%Daily Change-1.2%
$3.070Reference Price$8.260
+22.5%ROE+13.2%
+19.5%Profit Margin+36.1%

Active Signals

CGS Signals

●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.6x)
●Moderate revenue growth (+16%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week high (90% of range)

CUV Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Volume surging at 3.1x normal while price falls — heavy selling pressure
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.5x)

Ask Scout AI to compare CGS and CUV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CGS vs MVP →EYE vs IMM →AHC vs EYE →AHC vs ATH →ARX vs MVP →
CGS Full Analysis → CUV Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).